Showing results (131-140 of 257) with videos related to

Sort By:
Pageof 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1992
Hepatobiliary infections caused by Haemophilus speciesT A O'Bryan, C J Whitener, M Katzman, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis mediaM R Jacobs, R Dagan, P C Appelbaum, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|July 1, 1980
Colonization of nasal ulcers as a source of Candida parapsilosis fungemiaB S Shaikh, P C Appelbaum, J M Jones, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycinP C Appelbaum, S K Spangler, R Shiman, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1989
In vitro activity of YTR 830M R Jacobs, S C Aronoff, P C Appelbaum, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 28, 1980
Intestinal bacteria in patients with tropical sprueP C Appelbaum, M G Moshal, W Hift, et al.
The Journal of Infectious Diseases|June 1, 1975
Absence of hepatitis B antigens from feces and sewage as a result of enzymatic destructionW O Grabow, O W Prozesky, P C Appelbaum, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2006
Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005R Finch, P A Hunter
Antimicrobial Agents and Chemotherapy|January 20, 2000
In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniaeT A Davies, B E Dewasse, M R Jacobs, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 10, 2003
In vitro anti-anaerobic activity of the cephalosporin derivative RWJ 54428, compared to seven other compoundsD B Hoellman, L M Kelly, M R Jacobs, et al.
Pageof 26